Delivery Order SPE2DB22D2206-SPE2DB25FKC14
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for Orserdu 345 mg tablets (30-count units) on August 29, 2025, with an ultimate completion date of September 22, 2025. This firm fixed price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a $13,920.91 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This contract utilizes firm fixed price terms with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order represents a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for ORSERDU 86 mg tablets (30-count units) valued at $9,394.44 under a firm fixed-price contract type. This non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement within the military...
- The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award was issued on July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Orserdu 345 mg tablets (30-count packages) with a ceiling value of $27,841.82. This firm fixed-price delivery order, which is scheduled for completion by October 6, 2025, carries no set-aside designation and represents a competitively awarded contract. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for ORSERDU 345 mg tablets in a 30-count package configuration. This firm fixed-price delivery order, valued at $27,841.82, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. The delivery order was competitively awarded...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for the supply of Orserdu 345 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award was issued on September 16, 2025, with an ultimate completion date of October 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. The delivery order operates as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This $13,920.91 firm fixed price delivery order, which is scheduled for completion by September 10, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's significant Indefinite Delivery...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKC14Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for ORSERDU 345 mg tablets (30-count supply) on September 24, 2025, with completion targeted for October 16, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill this requirement through its extensive federal contracting experience and comprehensive pharmaceutical supply capabilities. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that serves as a global pharmaceutical support mechanism for military healthcare programs. The IDC enables the contractor to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's track record of consistent competitively awarded delivery orders across multiple therapeutic domains demonstrates its capability to meet the DLA's medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 9/24/25 |